Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abiraterone vs. MDV3100: A prostate cancer drug showdown
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Submitted by
admin
on May 19, 2011 - 2:08pm
Source:
Fierce Biotech
News Tags:
abiraterone
prostate cancer
Medivation
MDV3100
dimebon
Pfizer
Astellas
Headline:
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Do Not Allow Advertisers to Use My Personal information
